• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Atrial fibrillation and heart failure with reduced ejection fraction are increasing in prevalence
worldwide. Atrial fibrillation can precipitate and can be a consequence of heart failure with …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Aims To investigate the association between catheter ablation for atrial fibrillation (AF) and
mortality as well as hospitalization for heart failure (HF) in patients with HF across the …

Background: Atrial fibrillation (AF) and heart failure (HF) often coexist and synergistically
contribute to an increased risk of hospitalization, stroke, and mortality. Objective: To …

Introduction Increasing evidence has suggested improved outcomes in atrial fibrillation (AF)
patients with heart failure (HF) undergoing catheter ablation (CA) as compared to medical …

Background: Catheter ablation (CA) for atrial fibrillation (AF) has been proposed as a means
of improving outcomes among patients with heart failure and reduced ejection fraction …

Background The posterior wall of the left atrium may promote atrial fibrillation (AF) due to its
propensity for fibrosis, in addition to a high prevalence of non-pulmonary vein triggers …

Introduction Functional tricuspid regurgitation (TR) remains a challenging clinical problem
with poor outcomes and few effective treatments. Atrial fibrillation (AF) has been associated …